Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 10/20 | 0.65 |
| ▸ | MME | P08473 | 9/20 | 0.65 |
| ▸ | CPA1 | P15085 | 2/20 | 0.65 |
| ▸ | ACE2 | Q9BYF1 | 2/20 | 0.65 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.63 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2545591 | 1.00 | ACE (0.65) | ACEMMECPA1ACE2FOLH1 | |
| SCHEMBL31287928 | 1.00 | ACE (0.65) | ACEMMECPA1ACE2FOLH1 | |
| SCHEMBL4073351 | 1.00 | ACE (0.65) | ACEMMECPA1ACE2FOLH1 | |
| Water SCHEMBL20489337 | 0.98 | ACE (0.64) | ACEMMECPA1ACE2FOLH1 | |
| Water SCHEMBL20489335 | 0.98 | ACE (0.64) | ACEMMECPA1ACE2FOLH1 | |
| Water SCHEMBL29167817 | 0.98 | ACE (0.64) | ACEMMECPA1ACE2FOLH1 | |
| Water SCHEMBL29167825 | 0.98 | ACE (0.64) | ACEMMECPA1ACE2FOLH1 | |
| Water SCHEMBL20495306 | 0.98 | ACE (0.64) | ACEMMECPA1ACE2FOLH1 | |
| Water SCHEMBL29167818 | 0.98 | ACE (0.64) | ACEMMECPA1ACE2FOLH1 | |
| Water SCHEMBL29167821 | 0.98 | ACE (0.64) | ACEMMECPA1ACE2FOLH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 467 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4703370-A1 | AMINO ACID-DERIVED CERAMIDE, SYNTHESIS METHOD THEREFOR AND USE THEREOF | Shenzhen Dikeman Biotechnology Co., Ltd. (CN) | 2026-03-04 | — | — | EP | claimed |
| EP-4695413-A1 | PHOSPHONOALANINE OLIGOPEPTIDES AND METHODS OF MAKING AND USE THEREOF | Ohio State Innovation Foundation (US) | 2026-02-18 | — | — | EP | claimed |
| EP-4659591-A1 | TASTE-ENHANCING COMPOSITION, METHOD FOR PRODUCING SAME, FOOD PRODUCT, AND METHOD FOR ENHANCING TASTE OF FOOD PRODUCT | House Foods Group Inc. (JP) | 2025-12-10 | — | — | EP | claimed |
| EP-4659592-A1 | FLAVOR ENHANCING COMPOSITION, MANUFACTURING METHOD THEREFOR, AND METHOD FOR ENHANCING FLAVOR OF FOOD PRODUCT | House Foods Corporation (JP) | 2025-12-10 | — | — | EP | claimed |
| US-12377110-B2 | Fospropofol methods and compositions | EPALEX CORPORATION (US) | 2025-08-05 | — | — | US | claimed |
| CN-119732861-A | Application of dipeptide as soothing raw material, composition with soothing effect and cosmetic | 深圳瑞德林生物技术有限公司 | 2025-04-01 | — | — | CN | claimed |
| US-20250064706-A1 | PHOTOSTABILIZED COMPOSITIONS AND A METHOD FOR STABILIZING PHOTOSENSITIVE COMPONENTS | EVONIK OPERATIONS GMBH (DE) | 2025-02-27 | — | — | US | claimed |
| WO-2024222082-A1 | AMINO ACID-DERIVED CERAMIDE, SYNTHESIS METHOD THEREFOR AND USE THEREOF | 深圳市迪克曼生物科技有限公司 | 2024-10-31 | — | — | WO | claimed |
| WO-2024216031-A1 | PHOSPHONOALANINE OLIGOPEPTIDES AND METHODS OF MAKING AND USE THEREOF | OHIO STATE INNOVATION FOUNDATION (US) | 2024-10-17 | — | — | WO | claimed |
| CN-115894625-B | Polypeptide with anti-aging effect and application thereof | 桂林医学院 | 2024-08-27 | — | — | CN | claimed |
| WO-2001060420-A1 | A MEDICINAL AEROSOL FORMULATION | AEROPHARM TECHNOLOGY, INC. (US) | 2001-08-23 | — | — | WO | claimed |
| EP-1032262-A1 | METHODS AND COMPOSITIONS FOR ENHANCING CYTOCHROME P450 IN PLANTS | NONOMURA, Arthur M. (US) | 2000-09-06 | — | — | EP | claimed |
| US-6020288-A | PLANT GROWTH AGENT | NONOMURA ARTHUR M (US) | 2000-02-01 | — | — | US | claimed |
| WO-1999012417-A1 | METHODS AND COMPOSITIONS FOR ENHANCING CYTOCHROME P450 IN PLANTS | NONOMURA ARTHUR M (US) | 1999-03-18 | — | — | WO | claimed |
| EP-0182356-B2 | Nutrient compositions | MONTEFIORE HOSPITAL ASS OF WES (US) | 1998-08-05 | — | — | EP | claimed |
| EP-0512435-B1 | Method of crystallizing aspartame | AJINOMOTO KK (JP) | 1997-01-22 | — | — | EP | claimed |
| US-5298648-A | Method of crystallizing aspartame | AJINOMOTO CO., INC. (JP) | 1994-03-29 | — | — | US | claimed |
| EP-0436611-A4 | COMPOUND AND METHOD FOR THE RETARDATION OF COLLAGEN CROSS-LINKING | — | 1992-03-11 | — | — | EP | claimed |
| EP-0436611-A1 | COMPOUND AND METHOD FOR THE RETARDATION OF COLLAGEN CROSS-LINKING | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 1991-07-17 | — | — | EP | claimed |
| WO-1990006102-A1 | COMPOUND AND METHOD FOR THE RETARDATION OF COLLAGEN CROSS-LINKING | PEPTIDE TECHNOLOGY LIMITED (AU) | 1990-06-14 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12377110-B2 | Fospropofol methods and compositions | FOS, FOSB, PFAS | ACE 573/4885MME 2240/4885CPA1 2984/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.